Ipana 20% Benzocaine Topical Gel
Product Images NDC 69510-355

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Ipana 20% Benzocaine Topical (NDC 69510-355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Maxill Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lb.ipana-topical-gel-wrap_us.jpg (Lb.ipana Topical Gel Wrap Us)

Lb.ipana-topical-gel-wrap_us.jpg (Lb.ipana Topical Gel Wrap Us)
This is a drug fact sheet for an oral mucosal anesthetic containing benzocaine. It is intended for temporary relief of pain due to minor dental procedures and should be used only as directed by a dentist. Patients with a history of allergies to local anesthetics or who experience certain symptoms, such as weakness or difficulty breathing, should stop use and consult a healthcare practitioner. The drug should not be used for more than seven days unless directed by a dentist or doctor. If pregnant or breastfeeding, individuals should ask a health professional before use. The inactive ingredients include various flavorings, PEG, and color additives. The sheet contains contact information for questions and was manufactured for maxill inc. in Cortland, OH.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.